Children with hemophilia A require three to four infusions each week to prevent bleeding episodes, chronic pain and joint damage. A new, extended therapy combines recombinant factor VIII with a fusion protein that allows the molecule to remain in the circulation longer -- translating into a need for less frequent treatment.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1DwzP5g
No comments:
Post a Comment